Do you suffer from Keratoconus or Corneal Ectasia?

Dr. Lewis of James S. Lewis, MD PC in Elkins Park, PA is conducting an FDA sponsored clinical research trial to study an investigational treatment to stop or slow the progression of keratoconus and corneal ectasia. You may qualify to participate if you:

• are 12 years of age or older
• were diagnosed with keratoconus or were diagnosed with corneal ectasia after you received refractive surgery (e.g. LASIK, PRK)
• are able to come in for at least 8 office visits over a 12 month period

Please call James S. Lewis, MD at 215.886.9090 and ask to speak with Ashley for more information and to schedule an appointment.

Approved by Alpha IRB April 30, 2012

Click here to download the official pdf document

You have Keratoconus. Now what?

Once you are done asking the question, WHY ME? it is time to address the condition and move on with your life.

Keratoconus, Pellucid Marginal Degeneration, Keratoglobus, Irregular Astigmatism, and post-LASIK Ectasia as well as Forme Fruste variants of these conditions are more common than you think. Fortunately, excellent treatment exists and new modalities are finally achieving FDA approval.

The most effective approach to keratoconus treatment, or more properly phrased, ectasia management, is highly individualized. Experienced and creative exploration of techniques from minimally invasive, to more aggressive and definitive care is the fastest path to a solution.

We have a full spectrum of diagnostics including tear film assessment, topography and wavefront analysis, confocal microscopy, optical coherence tomography, and HD video imaging. Our therapeutic options include Intacs, Intralase (femtosecond laser tunneling**), collagen crosslinking* (CXL or KXL), DALK (Deep Anterior Lamellar Keratoplasty), MDALK (Maximal DALK, Big Bubble), Full Thickness Keratoplasty (Corneal Transplant), and Excimer Laser post-keratoplasty Corneal Resculpting.

Located on the campus of The Pennsylvania College of Optometry of Salus University, we have unparalleled access to the leading authorities in specialty contact lenses, customized contact lenses, and topographically guided lens manufacture.

The literature claims over 50% of corneal transplant patients still require RGP (rigid gas-permeable) contact lenses after surgery. Our practice has less than 10% who still require any kind of contact lens. This is the result of ERAPK, Advanced Surface Ablation for Excessive Regular Astigmatism following Peneetrating keratoplasty, a concept Dr. Lewis submitted to the FDA over a decade ago. Our practice enjoys the largest series of ERAPK treatments worldwide.

Patients with early or forme fruste keratoconus can, and probably should be evaluated for collagen crosslinking. If appropriate, we believe this will halt and, in some cases, reverse much of the visual degradation.

We intend to expand this website with more relevant material. For a consultation, please call 215 886-9090.

*authorized FDA Clinical Trial Site